Ozempic economics: How GLP-1s will disrupt the economy in 2025
washingtonpost.com
washingtonpost.com
Most people forget that US Medicare isn't true universal, single-payer healthcare and is an excessively-complex, oft corporation-involved, half-measure. It is mostly better than Medicaid, healthcare for the very poor, which is even worse. Medicare Advantage is a total scam.
Compounding pharmacies can make generic semaglutide, the active ingredient in Ozempic and Wegovy. It's a synthetic chemical, so the medication should be functionally equivalent, although the FDA points out that in some cases compounding pharmacies make the wrong thing/dosage [1]. When done this way, the drug is not FDA-approved. But may be worth a shot.
Manufacturers are also complaining about patent infringement [1], so we will see how long this practice lasts.
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information...
[2] https://www.npr.org/sections/shots-health-news/2024/11/20/nx...
Buy your own tirzepatide from china. QSC batches all have purity tests, and cost about $200 for 400mg which will last a good year at a reasonable dose regimen
1. The reputation and business license of my local compounding pharmacy is on the line, so they cannot afford to sell anything fake.
2. Buying from China is likely fake crap, with fake purity tests.
Why would I gamble with my life to save 20% when I have a trustworthy source given to me from my doctor (who is not receiving any sort of kickback but is familiar with this specific opportunistic workaround)?
https://www.bloomberg.com/opinion/articles/2021-02-24/the-va... | https://archive.is/2021.02.24-173233/https://www.bloomberg.c...
I see parallels in this. GLP-1s are going to be incredibly disruptive and there is an argument to be made that some interested parties might be incentivized to pull forward the eventuality of deployment at scale of this intervention. Of course, some industries are going to be impaired (food, alcohol); acceptable losses imho, businesses that profited and existed due to a malfunctioning reward center now patched with GLP-1s.
I also think it's likely you are actually in the other class than what you believe.
I think the reason that hasn't happened (and that this public good mass vaccination attempt won't either) is that it would require a huge bet against a whole industry, the healthcare industry as it is. It goes maximally against the spirit of index funds/a balanced portfolio. Even if you pulled it off, wouldn't other people still reap most of the benefits too?